Lunning, M. A., Maus, M. V., Ellithi, M., Toron, F., Braun, R., Wang, L., Wang, P., Jones, M., Elsallab, M. (2025). Postmarketing safety profile of chimeric antigen receptor (CAR) T cell therapies in diffuse large B-cell lymphoma (DLBCL): Analysis of real-world (RW) AE reporting from the FDA Adverse Event Reporting System (FAERS).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7028